SHS News Current page: 4

Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies that focus on medical technology and the life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]

The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you an overview of the current development of medical technology in Germany, Europe, the USA and Asia: from a legal, technical and transaction-oriented perspective. Due […]

On April 1, 2020, Sascha Alilovic (46) was appointed Managing Partner of SHS Gesellschaft für Beteiligungsmanagement. Whether by way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies with a focus on medical technology and life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]

Neuro Event Labs Oy closes EUR 3.9m Series A investment round from Hadean Ventures, SHS Gesellschaft für Beteiligungsmanagement and Maki.vc Proceeds to support commercial expansion in Europe as well as US market entry Investment round led by Hadean Ventures, joined by SHS Gesellschaft für Beteiligungsmanagement and existing investor Maki.vc Neuro Event Labs Oy today announced […]

Blazejewski MEDI-TECH GmbH is a leading manufacturer of medical endoscopes SHS is acquiring a 24.9-percent stake in the company Blazejewski intends to advance sales and internationalization with the aid of SHS SHS Gesellschaft fuer Beteiligungsmanagement mbH, the Tuebingen-based investor in medical technology and life sciences, is investing in Baden-Wuerttemberg-based endoscope specialist Blazejewski MEDI-TECH GmbH. The […]

Selfapy is Germany’s leading provider of online therapy for mental stress and is already cooperating with 16 health insurance funds SHS is expecting strong impulses for digital health companies from Germany’s new Digital Healthcare Act (DVG) Fifth investment of SHS’ fifth fund: Medical technology and life science investor SHS Gesellschaft für Beteiligungsmanagement of Tübingen, Germany, […]

As a solution provider for the life science industry, Single Use Support (SUS) increases patient safety and minimizes the risk of contamination SUS customers include well-known companies from Europe, Asia and America SUS platform technology can become the industry standard for fluid logistics processes in the life science, biotech, pharmaceutical and medical device industries The […]

Although the performance of the medical technology sector is still well above that of the economy as a whole, the relative growth rate has been in decline for the past two years The Medical Device Regulation introduced in 2017 may have slowed the sector’s growth momentum Small and medium-sized companies in particular require more capital […]

Third investment from fifth SHS fund – development of a diversified portfolio of medical technology and life science companies TTübingen-based medical technology investor SHS Gesellschaft für Beteiligungsmanagement mbH has invested a mid single-digit million amount from its fifth fund in Betterguards Technology GmbH. The technology developed and produced by the Berlin-Brandenburg-based company is primarily aimed […]

The SHS V fund managed by Tübingen-based SHS Gesellschaft für Beteiligungsmanagement has acquired a joint stake in Swiss evitria AG together with AFINUM. The life science company supplies large pharmaceutical and biotech companies with customized antibodies for research purposes. For SHS, it is the first investment from its SHS V fund, which had its first […]

SHS Gesellschaft fuer Beteiligungsmanagement, MBG Baden-Württemberg and VC Fonds BW announced that Emerging Implant Technologies GmbH (EIT), a manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, has been acquired by Johnson & Johnson Medical GmbH. SHS became EIT’s lead investor in September 2016. Since then the Tuebingen based medtech specialist has subsequently supported […]

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over €90 million in its fifth fund’s first closing. The Tuebingen-based medical technology investor has thus reached almost two thirds of its target of €150 million faster than expected. The fifth generation of SHS funds is also focused on the life sciences and medical technology sector, […]